Hypertriglyceridemia Diagnosis and Management

Initial Assessment and Classification

The American College of Cardiology recommends obtaining at least two fasting lipid panels, preferably 2 weeks apart, to confirm the diagnosis and guide treatment decisions 1
Measure fasting triglycerides, total cholesterol, HDL-C, and calculate LDL-C using the Martin-Hopkins method for more accurate LDL-C assessment in hypertriglyceridemia 1
Calculate non-HDL cholesterol (total cholesterol minus HDL-C) with a target goal of <130 mg/dL for moderate hypertriglyceridemia 1, 2
Classify severity: Mild (150-199 mg/dL), Moderate (200-499 mg/dL), Severe (500-999 mg/dL), Very Severe (≥1,000 mg/dL) 1, 2

Screen systematically for reversible causes before initiating pharmacotherapy, as treating these conditions may eliminate the need for lipid-lowering medications 1, 2
Assess for diabetes mellitus or prediabetes using hemoglobin A1c and fasting glucose, as poor glycemic control is often the primary driver of severe hypertriglyceridemia 1
Measure thyroid-stimulating hormone (TSH) to rule out hypothyroidism 1, 2
Assess for chronic kidney disease or nephrotic syndrome using serum creatinine and estimated GFR 1, 2

Evaluate for other components of metabolic syndrome and cardiovascular risk factors to guide comprehensive management 1, 2
Assess for central obesity (waist circumference), hypertension, and abnormal glucose metabolism 2
Calculate 10-year ASCVD risk using the pooled cohort equations for patients aged 40-75 years to determine statin therapy indications 1
Obtain detailed family history of premature cardiovascular disease, dyslipidemia, and genetic lipid disorders 1, 2

Conduct a thorough medication review and assess lifestyle factors that contribute to hypertriglyceridemia 1, 2
Review medications that elevate triglycerides: thiazide diuretics, beta-blockers, estrogen therapy, corticosteroids, bile acid sequestrants, antiretroviral protease inhibitors, immunosuppressants, and antipsychotics 1, 2
Quantify alcohol consumption, as even 1 ounce daily increases triglycerides by 5-10%, and complete abstinence is mandatory for severe hypertriglyceridemia (≥500 mg/dL) 1
Assess dietary intake of added sugars, saturated fats, and total fat consumption 1

For patients with triglycerides ≥500 mg/dL, prioritize urgent evaluation to prevent acute pancreatitis 3, 4
Consider genetic testing for familial chylomicronemia syndrome or familial combined hyperlipidemia in cases of severe primary hypertriglyceridemia, especially if family history is positive 1
Assess for multifactorial chylomicronemia syndrome, which is 40-60 fold more prevalent than monogenic conditions and results from genetic predisposition combined with secondary factors 1

Establish baseline values before initiating therapy and schedule appropriate follow-up 1, 3
Reassess fasting lipid panel in 6-12 weeks after implementing lifestyle modifications, or 4-8 weeks after initiating or adjusting pharmacotherapy 1, 3